Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

Multicompartment Models: Overview

Multicompartment Models: Overview

Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer's disease: a Bayesian meta-analysis.

Journal of comparative effectiveness research·2025

Same author

Combining treatment effects from mixed populations in meta-analysis: a review of methods.

BMC medical research methodology·2025

Same author

Technology Assessment vs. Technology Appraisal-How to Strengthen the Science/Value Dichotomy with EU HTA?

Journal of market access & health policy·2024

Same author

Human blood cell transcriptomics unveils dynamic systemic immune modulation along colorectal cancer progression.

Journal for immunotherapy of cancer·2024

Same author

Innovative Biomarkers for Obesity and Type 1 Diabetes Based on <i>Bifidobacterium</i> and Metabolomic Profiling.

Microorganisms·2024

Same author

Estimating the prevalence of diagnosed Alzheimer disease in England across deprivation groups using electronic health records: a clinical practice research datalink study.

BMJ open·2023

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

Heterogeneity in multistage carcinogenesis and mixture modeling.

Sandro Gsteiger¹, Stephan Morgenthaler

¹Institute of Mathematics, Swiss Federal Institute of Technology, Lausanne, Switzerland. sandro.gsteiger@a3.epfl.ch

Theoretical Biology & Medical Modelling

|July 23, 2008

Summary

Mixture modeling extends the multistage carcinogenesis model to account for population heterogeneity. This approach identified a small high-risk group and a large, nearly immune group in human lung cancer data.

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Related Experiment Videos

Last Updated: Jul 3, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Area of Science:

Epidemiology
Biostatistics
Cancer Research

Background:

Carcinogenesis is a multistage process involving stem cell mutations.
Understanding population heterogeneity is crucial for accurate cancer modeling.

Purpose of the Study:

To extend the multistage carcinogenesis model using finite mixture models.
To analyze population heterogeneity in human lung cancer data.

Main Methods:

Finite mixture models were developed and their identifiability proven.
Analytic graduation was used due to heavy data censoring, as maximum likelihood estimation performed poorly.
Models were applied to human lung cancer data from multiple birth cohorts.

Main Results:

Finite mixture models provide a biologically meaningful way to describe population heterogeneity.
Models combining a small high-risk group with a large, quasi-immune group achieved very good fits.
Analytic graduation proved effective for analyzing heavily censored cancer data.

Conclusions:

Mixture modeling offers a robust extension to the multistage carcinogenesis framework.
Human lung cancer data suggests distinct risk groups within the population.
The findings highlight the importance of accounting for heterogeneity in cancer epidemiology.